← Leaderboards
Ravi Thadhani
Brigham And Women'S Hospital
$43,973,148
Attributed
$45,850,582
Total exposure
23
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.4M · FY2005–24$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$45,850,582 · 23
By mechanism
P51$33,593,259 · 1
R01$8,909,272 · 7
R21$1,140,898 · 3
T32$773,344 · 1
K24$545,930 · 1
R24$492,908 · 1
Top collaborators
- Thomas J Wang5 shared
- S Ananth Karumanchi4 shared
- Anil K Chandraker1 shared
- Laura M Dember1 shared
- Robert E Gerszten1 shared
- Martin R. Pollak1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Charles S Fuchs$37,354,862
- Rulla M Tamimi$15,389,173
- David Evan Leaf$10,646,805
- John P Forman$11,830,902
- Ellen W Seely$4,806,814
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseResearch PersonnelClinical ResearchFundingBiologyUnited States National Institutes Of HealthGrantVitamin DLinkScientistBiologicalReportingGene ExpressionChronic Kidney FailureInflammatoryInnovationResourcesMorbidity - Disease RateCohortLeadResponseCytokineEnsureEnd Stage Renal Failure
Grant awards (59)
Emory National Primate Research Center$10,751,414
P51 · FY2024 · OD · contact PI
Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC$499,316
P51 · FY2024 · OD · contact PI
Emory National Primate Research Center$169,851
P51 · FY2024 · OD · contact PI
Emory National Primate Research Center$10,751,414
P51 · FY2023 · OD · contact PI
Emory National Primate Research Center: Building Automation System Upgrade$499,999
P51 · FY2023 · OD · contact PI
Support of the Emory National Primate Research Center$169,851
P51 · FY2023 · OD · contact PI
Emory National Primate Research Center$10,751,414
P51 · FY2022 · OD · contact PI
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$440,709
R01 · FY2018 · DK · contact PI
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$440,709
R01 · FY2017 · DK · contact PI
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$440,709
R01 · FY2016 · DK · contact PI
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease$109,186
K24 · FY2016 · DK · contact PI
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$459,209
R01 · FY2015 · DK · contact PI
Training in cell structure and function in nephrology$401,767
T32 · FY2015 · DK · contact PI
Impact of vitamin D supplementation on cardiac structure and function$264,464
R01 · FY2015 · HL
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease$109,186
K24 · FY2015 · DK · contact PI
Impact of vitamin D supplementation on cardiac structure and function$32,241
R01 · FY2015 · HL
Bioavailable Vitamin D Redefines Vitamin D Deficiency$377,570
R01 · FY2014 · DK · contact PI
Training in cell structure and function in nephrology$371,577
T32 · FY2014 · DK · contact PI
Impact of vitamin D supplementation on cardiac structure and function$294,801
R01 · FY2014 · HL
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease$109,186
K24 · FY2014 · DK · contact PI
PDE5i with Tadalafil Changes the Extent of Renal Damage (PITCH_ER)$412,599
R01 · FY2013 · HL · contact PI
Bioavailable Vitamin D Redefines Vitamin D Deficiency$364,355
R01 · FY2013 · DK · contact PI
Impact of vitamin D supplementation on cardiac structure and function$286,325
R01 · FY2013 · HL
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease$109,186
K24 · FY2013 · DK · contact PI
Bioavailable Vitamin D Redefines Vitamin D Deficiency$394,046
R01 · FY2012 · DK · contact PI
Dialysis Infection and Vitamin D in New England: The DIVINE Study$378,610
R01 · FY2012 · DK · contact PI
Impact of vitamin D supplementation on cardiac structure and function$307,048
R01 · FY2012 · HL
Soluble EPO Receptor and EPO Resistance in Dialysis$175,500
R21 · FY2012 · HL · contact PI
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease$109,186
K24 · FY2012 · DK · contact PI
Clinical characterization of the APOL1-associated phenotype$492,908
R24 · FY2011 · DK
Dialysis Infection and Vitamin D in New England: The DIVINE Study$456,355
R01 · FY2011 · DK · contact PI
Translational Studies Examining Soluble EPO Receptor and EPO Resistance in Dialys$326,010
R21 · FY2011 · HL · contact PI
Ergocalciferol in ESRD Efficacy Safety and Biology$442,500
R01 · FY2010 · DK · contact PI
Ergocalciferol in ESRD Efficacy Safety and Biology$442,292
R01 · FY2009 · DK · contact PI
MACS - METABOLIC ABNORMALITIES IN COLLEGE STUDENTS$16,351
M01 · FY2008 · RR · contact PI
Vitamin D and Cardiovascular Disease$10,000
R13 · FY2008 · HL · contact PI
METABOLIC ALTERATIONS IN WOMEN WITH A HISTORY OF HYPERTENSIVE DISORDERS OF PREG$4,533
M01 · FY2008 · RR · contact PI
HCAP18 LEVELS AND VITAMIN D DEFICIENCY IN HEALTHY SUBJECTS$4,047
M01 · FY2008 · RR · contact PI
Gestational Diabetes and Preeclampsia Cytokine Profiles$231,699
R01 · FY2007 · DK · contact PI
MACS - METABOLIC ABNORMALITIES IN COLLEGE STUDENTS$6,430
M01 · FY2007 · RR · contact PI
METABOLIC ALTERATIONS IN WOMEN WITH A HISTORY OF HYPERTENSIVE DISORDERS OF PREG$5,143
M01 · FY2007 · RR · contact PI
Gestational Diabetes and Preeclampsia Cytokine Profiles$247,318
R01 · FY2006 · DK · contact PI
Biological Measures and Hemodialysis Mortality$170,888
R21 · FY2006 · DK · contact PI
METABOLIC ALTERATIONS IN WOMEN WITH A HISTORY OF HYPERTENSIVE DISORDERS OF PREG$5,339
M01 · FY2006 · RR · contact PI
ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES$372,825
R01 · FY2005 · HD
Gestational Diabetes and Preeclampsia Cytokine Profiles$291,700
R01 · FY2005 · DK
Biological Measures and Hemodialysis Mortality$175,000
R21 · FY2005 · DK
Antibody Microarray Predicting Pima Diabetic Nephropathy$137,500
R21 · FY2005 · DK
METABOLIC ALTERATIONS IN WOMEN WITH A HISTORY OF HYPERTENSIVE DISORDERS OF PREG$8,607
M01 · FY2005 · RR
ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES$372,825
R01 · FY2004 · HD
Antibody Microarray Predicting Pima Diabetic Nephropathy$156,000
R21 · FY2004 · DK
METABOLIC ALTERATIONS IN WOMEN WITH A HISTORY OF HYPERTENSIVE DISORDERS OF PREG$29,313
M01 · FY2004 · RR
ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES$381,423
R01 · FY2003 · HD
ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES$21,961
R01 · FY2003 · HD
ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES$372,825
R01 · FY2002 · HD
HYPERTENSIVE DISORDERS OF PREGNANCY$101,736
K08 · FY2002 · HL
ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES$382,154
R01 · FY2001 · HD
HYPERTENSIVE DISORDERS OF PREGNANCY$101,736
K08 · FY2001 · HL
HYPERTENSIVE DISORDERS OF PREGNANCY$101,736
K08 · FY2000 · HL